Transmural Systems
$36M+ Funding Accelerates Innovative Cardiology Device Development
AstraZeneca
AstraZeneca Secures $11M+ to Advance a First-in-class Therapy into Phase 2 Clinical Trial for Opioid Use Disorder
AgroSpheres
NSF Seed Funding Powers Pesticide Degradation Startup to $45M+ in Investment
WinSanTor
Over $40M in Funding Propels Neuropathy Therapy to Phase 3 Clinical Trials
Kepley Biosystems
Kepley Biosystems Thrives with EGC’s Expert Accounting, Advancing Sustainable Technologies Since 2015.
InnAVasc
Duke Innovation Advanced with SBIRs and Acquired by W. L. Gore & Associates
Lightengale
Integrated Scientific and Accounting Expertise Advances Lightengale’s IV Tubing Technology
Bezwada Biomedical
Bezwada Biomedical has secured $1.6 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Scioto Biosciences
$2.3M NIH Grant Catalyzes $26.5M Series B to Advance Probiotic Treatments for Necrotizing Enterocolitis and Autism
Dignify Therapeutics
$20M in Non-Dilutive Funding Advances Breakthrough Therapies for Spinal Injury Patients
Ascent Integrated Tech
Protecting Those in Harm’s Way: Ascent Integrated Technology Secures $7.3M to Advance Warfighter Readiness
Laser Thermal
DoW and NIST Funding of $7.5M Accelerates Laser Thermal’s Leadership in Metrology
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.